Medicine and Dentistry
Therapeutic Procedure
100%
Patient
88%
Percutaneous Coronary Intervention
72%
Follow up
58%
Inpatient
54%
Stent
45%
Rapamycin
45%
Lesion
45%
Coronary Computed Tomography Angiography
45%
Tissue Engineering
45%
Coronary Occlusion
45%
Chronic Total Occlusion
45%
Randomized Clinical Trial
45%
Serum
27%
Target Lesion
24%
Myocardial Infarction
22%
Adipose Tissue
18%
Cell Growth
18%
Complication
18%
Heart Muscle Revascularization
13%
Drug Therapy
13%
Heart Failure
9%
Association
9%
Culture
9%
Donor
9%
Adverse Event
9%
Cardiovascular System
9%
Cohort Analysis
9%
Angina Pectoris
9%
Patient Characteristics
9%
New York Heart Association Class
9%
Heart
9%
Hospital
9%
Heart Muscle Ischemia
9%
Incidence
8%
Target Lesion Revascularization
8%
Gender
5%
Pharmacology, Toxicology and Pharmaceutical Science
Sirolimus
90%
Stent
45%
Pharmacotherapy
32%
Clinical Trial
22%
Eagle
22%
Cohort Study
9%
Normal Human
7%
Antiplatelet
6%
Sulfanilamide
6%